Prolactin and smoking status in antipsychotic-treated patients

  1. Lookup NU author(s)
  2. Dr Paul Mackin
  3. Dr Amit Nulkar
  4. Anthony Waton
  5. Helen Watkinson
Author(s)Mackin P, Nulkar A, Waton T, Watkinson HMO
Publication type Article
JournalJournal of Psychopharmacology
Year2011
Volume25
Issue5
Pages698-703
ISSN (print)0269-8811
ISSN (electronic)1461-7285
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Studies investigating the relationship between cigarette smoking and prolactin secretion in the general population have yielded inconsistent results. Many antipsychotic drugs increase prolactin secretion, but there are no published studies that have investigated the relationship between smoking and prolactinaemia in antipsychotic-treated patients. We obtained prolactin levels from 228 antipsychotic-treated patients in secondary care mental health services and investigated the relationship between prolactinaemia and cigarette smoking. Twenty-three percent (n = 52) of patients had hyperprolactinaemia. Patients prescribed typical or a combination of typical and atypical antipsychotics had a significantly higher prevalence of hyperprolactinaemia and higher mean prolactin concentration. Both current and ex-cigarette smokers had significantly lower mean prolactin levels and a lower prevalence of hyperprolactinaemia, but after controlling for potentially confounding variables, only current smoking status was a significant predictor of lower prolactin levels (OR 2.3, 95% CI 1.2 to 4.7, p = 0.002). In this preliminary, cross-sectional study, there was a robust statistical relationship between cigarette smoking and prolactinaemia. The mechanism(s) underpinning this association needs further investigation.
PublisherSage Publications Ltd.
URLhttp://dx.doi.org/10.1177/0269881110379289
DOI10.1177/0269881110379289
PubMed id20699354
Actions    Link to this publication